ACTIVE

HUMAPHARM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

117,3 k €

+4.3% YoY

Gross margin

407,7 k €

+2.8% YoY

Equity

253 k €

-6.5% YoY

Workforce

2,9 ETP

0.0% YoY

What does HUMAPHARM do?

HUMAPHARM is a Public limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Libramont-Chevigny. It employs on average 2,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0443.844.680

Incorporation

14/04/1991

Legal form

Public limited company

Registered office

Libramont,Grand'rue 52
6800 Libramont-Chevigny · WallonieSee on map

Contributed capital

142 538,78 €

Latest accounts

31/12/2025

Average workforce

2,9 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 51460Air transport

Joint committees (1)

Signals

ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	407,7 k €	+2.8%	396,5 k €	-17.5%	480,3 k €	+14.8%	418,3 k €	+8.2%	386,7 k €	-25.1%	516,1 k €	+42.8%	361,4 k €	-13.8%	419,3 k €	+31.8%	318,2 k €	-2.8%	327,5 k €	-2.6%	336,2 k €	+11.2%	302,5 k €	+35.0%	224,1 k €	+25.9%	178 k €	+6.9%	166,6 k €	+83.2%	90,9 k €	+8.9%	83,5 k €	-6.0%	88,8 k €	+464%	15,7 k €	-85.7%	109,9 k €
EBITDA	244,4 k €	+3.7%	235,8 k €	-30.2%	337,9 k €	+26.0%	268,3 k €	+12.0%	239,5 k €	-37.8%	385,1 k €	+66.8%	230,9 k €	-17.8%	281 k €	+46.4%	191,9 k €	-17.2%	231,8 k €	+10.5%	209,8 k €	+0.9%	208 k €	+29.3%	160,8 k €	+43.9%	111,8 k €	+11.2%	100,6 k €	+84.7%	54,4 k €	+13.6%	47,9 k €	-33.1%	71,6 k €	+1452%	-5,3 k €	-112%	45,7 k €
Operating result	169,1 k €	+3.9%	162,8 k €	-39.2%	267,6 k €	+33.1%	201,1 k €	+13.1%	177,8 k €	-45.3%	325,2 k €	+109%	155,9 k €	-29.1%	219,8 k €	+58.6%	138,5 k €	-21.6%	176,6 k €	+16.0%	152,2 k €	+0.4%	151,6 k €	+35.6%	111,8 k €	+52.9%	73,1 k €	+12.5%	65 k €	+192%	22,3 k €	-39.2%	36,7 k €	-39.7%	60,8 k €	+506%	-15 k €	-140%	37,2 k €
Net result	117,3 k €	+4.3%	112,5 k €	-55.6%	253,3 k €	+39.1%	182,2 k €	+13.5%	160,5 k €	-47.1%	303,3 k €	+120%	137,8 k €	-30.9%	199,5 k €	+17.2%	170,2 k €	-10.0%	189,2 k €	+3.2%	183,2 k €	-1.5%	186 k €	+29.6%	143,5 k €	+33.4%	107,5 k €	+10.7%	97,1 k €	+203%	32,1 k €	-40.8%	54,1 k €	-30.2%	77,5 k €	+751%	9,1 k €	-65.4%	26,3 k €
Balance sheet
Equity	253 k €	-6.5%	270,7 k €	-2.7%	278,3 k €	+1.2%	274,9 k €	+0.1%	274,8 k €	+0.2%	274,3 k €	+1.0%	271,6 k €	+5.6%	257,3 k €	+0.4%	256,3 k €	+0.1%	256,1 k €	+0.1%	255,9 k €	+0.1%	255,7 k €	+1.2%	252,7 k €	+2.2%	247,2 k €	+2.9%	240,1 k €	+3.1%	233 k €	+3.4%	225,4 k €	+3.5%	217,8 k €	+9.8%	198,3 k €	-54.9%	439,2 k €
Total assets	1,3 M €	+0.8%	1,3 M €	-5.3%	1,3 M €	+0.5%	1,3 M €	+1.8%	1,3 M €	-2.1%	1,3 M €	+18.9%	1,1 M €	+21.7%	927,6 k €	+0.0%	927,3 k €	-13.7%	1,1 M €	+4.8%	1 M €	+19.7%	856,4 k €	+13.9%	751,7 k €	+15.3%	651,8 k €	+8.4%	601,3 k €	-11.7%	681,2 k €	+94.2%	350,8 k €	-0.5%	352,6 k €	-30.7%	509 k €	+4.8%	485,8 k €
Cash	349,4 k €	-11.5%	395 k €	+71.7%	230,1 k €	-43.7%	408,6 k €	+38.0%	296,1 k €	+22.5%	241,7 k €	+31.9%	183,3 k €	+69.1%	108,4 k €	+31.3%	82,6 k €	+8.6%	76,1 k €	-37.8%	122,2 k €	-8.3%	133,3 k €	+7.9%	123,6 k €	+114%	57,8 k €	-29.3%	81,8 k €	-56.8%	189,3 k €	+266%	51,7 k €	+19.1%	43,4 k €	+1137%	3,5 k €	-88.1%	29,5 k €
Debts	1 M €	+2.8%	995,6 k €	-6.1%	1,1 M €	+1.0%	1 M €	+5.5%	994,1 k €	-6.4%	1,1 M €	+25.4%	847,2 k €	+28.9%	657,4 k €	-1.8%	669,3 k €	-18.1%	816,9 k €	+6.5%	767 k €	+28.0%	599,2 k €	+20.7%	496,5 k €	+23.2%	403 k €	+12.3%	358,8 k €	-19.8%	447,3 k €	+260%	124,3 k €	-7.2%	134 k €	-56.7%	309,7 k €	+630%	42,4 k €
Other
Workforce	2,9 ETP	0.0%	2,9 ETP	+3.6%	2,8 ETP	-3.4%	2,9 ETP	-3.3%	3,0 ETP	+3.4%	2,9 ETP	+3.6%	2,8 ETP	+16.7%	2,4 ETP	+9.1%	2,2 ETP	-8.3%	2,4 ETP	-7.7%	2,6 ETP	+36.8%	1,9 ETP	+26.7%	1,5 ETP	0.0%	1,5 ETP	-11.8%	1,7 ETP	+30.8%	1,3 ETP	+62.5%	0,8 ETP		–		0,2 ETP	-80.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 13 ended

Active mandates

Pharmacie Pierret-Ducoffre

Director · 0882.476.702

Represented by PIERRET Benoit François

Active

Ended mandates

Marie-Astrid Ducoffre

Director · since 01 décembre 2018 · until 01 décembre 2024

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

At this address

Other companies at this address

Company	CBE no.
Pharmacie Pierret-Ducoffre● Active	0882.476.702

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	30/06/2025	27/06/2024	31/08/2023	31/08/2022	24/08/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	01/06/2023	01/06/2022	01/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	01/06/2026	29/06/2026	French	PDF
Abridged model	31/12/2024	02/06/2025	30/06/2025	French	PDF
Abridged model	31/12/2023	03/06/2024	27/06/2024	French	PDF
Abridged model	31/12/2022	01/06/2023	31/08/2023	French	PDF
Abridged model	31/12/2021	01/06/2022	31/08/2022	French	PDF
Abridged model	31/12/2020	01/06/2021	24/08/2021	French	PDF
Abridged model	31/12/2019	31/08/2020	29/09/2020	French	PDF
Abridged model	31/12/2018	01/06/2019	23/09/2019	French	PDF
Abridged model	31/12/2017	01/06/2018	29/06/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	29/08/2017	French	PDF
Abridged model	31/12/2015	01/06/2016	19/08/2016	French	PDF
Abridged model	31/12/2014	01/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	01/06/2014	18/07/2014	French	PDF
Abridged model	31/12/2012	01/06/2013	22/06/2013	French	PDF
Abridged model	31/12/2011	01/06/2012	16/06/2012	French	PDF
Abridged model	31/12/2010	01/06/2011	22/06/2011	French	PDF
Abridged model	31/12/2009	01/06/2010	14/06/2010	French	PDF
Abridged model	31/12/2008	02/06/2009	10/06/2009	French	PDF
Abridged model	31/12/2007	01/06/2008	25/06/2008	French	PDF
Abridged model	31/12/2006	22/06/2007	11/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 13 ended

Active mandates

Pharmacie Pierret-Ducoffre

Director · 0882.476.702

Represented by PIERRET Benoit François

Active

Ended mandates

Marie-Astrid Ducoffre

Director · since 01 décembre 2018 · until 01 décembre 2024

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

Pharmacie Pierret-Ducoffre

Managing director · since 01 décembre 2018 · until 01 décembre 2024 · 0882.476.702

Represented by Benoit Pierret

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other01/02/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates06/02/2019
DEMISSIONS, NOMINATIONS
PDF
Other16/07/2015
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates28/06/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates15/12/2006
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025117,3 k €↑
2024
Annual accounts 2024112,5 k €↓
2023
Annual accounts 2023253,3 k €↑
2022
Annual accounts 2022182,2 k €↑
2021
Annual accounts 2021160,5 k €↓
2020
Annual accounts 2020303,3 k €↑
2019
Annual accounts 2019137,8 k €↓
2018
Annual accounts 2018199,5 k €↑
2017
Annual accounts 2017170,2 k €↓
2016
Annual accounts 2016189,2 k €↑
2015
Annual accounts 2015183,2 k €↓
2014
Annual accounts 2014186 k €↑
2013
Annual accounts 2013143,5 k €↑
2012
Annual accounts 2012107,5 k €↑
2011
Annual accounts 201197,1 k €↑
2010
Annual accounts 201032,1 k €↓
2009
Annual accounts 200954,1 k €↓
2008
Annual accounts 200877,5 k €↑
2007
Annual accounts 20079,1 k €↓
2006
Annual accounts 200626,3 k €
14/04/1991
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

HUMAPHARM

Overview

What does HUMAPHARM do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline